0001567619-21-008804.txt : 20210430
0001567619-21-008804.hdr.sgml : 20210430
20210430163824
ACCESSION NUMBER: 0001567619-21-008804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210428
FILED AS OF DATE: 20210430
DATE AS OF CHANGE: 20210430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stilwell McDavid
CENTRAL INDEX KEY: 0001851389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36721
FILM NUMBER: 21878870
MAIL ADDRESS:
STREET 1: C/O COHERUS BIOSCIENCES, INC.
STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coherus BioSciences, Inc.
CENTRAL INDEX KEY: 0001512762
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273615821
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: (650) 649-3530
MAIL ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: BioGenerics, Inc.
DATE OF NAME CHANGE: 20110210
4
1
doc1.xml
FORM 4
X0306
4
2021-04-28
0
0001512762
Coherus BioSciences, Inc.
CHRS
0001851389
Stilwell McDavid
COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE, SUITE 600
REDWOOD CITY
CA
94065
0
1
0
0
Chief Financial Officer
Common Stock
2021-04-28
4
A
0
20000
0.00
A
30000
D
Stock Option (Right to Buy)
14.76
2021-04-28
4
A
0
50000
0.00
A
2031-04-28
Common Stock
50000
50000
D
Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/2 of the RSUs vest annually on April 1 of each year, with the first 1/2 vesting on April 1, 2022 and with the RSUs being fully vested on April 1, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Includes 30,000 RSUs.
The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 8, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ McDavid Stilwell
2021-04-30